Hyderabad's odd position in the GLP-1 story
Every generic semaglutide conversation in India eventually routes through Hyderabad. Dr. Reddy's Laboratories — maker of the Obeda injection and the ₹99 Obeda oral tablet launched in May 2026 — is headquartered here. So is Natco Pharma, whose Semanat vials at roughly ₹1,290 a month set the floor price for the entire category when the semaglutide patent expired on 20 March 2026. Add Genome Valley's manufacturing cluster and the city's dense ecosystem of pharma professionals, and you get a population that is unusually literate about generics — and unusually quick to ask the practical question: if it's made here, why would I overpay for the Danish brand?
That literacy shows up in the data. Hyderabad is the second-most-mentioned Indian city in the country's largest GLP-1 community discussions, behind only Bangalore. The questions skew practical: which generic brand, what dose equivalence, which pharmacy actually has stock.
The generic-first price table (June 2026)
Because Hyderabad's GLP-1 buyers lean generic-curious, here's the market sorted the way this city actually shops — cheapest viable option first:
| Option | Maker (HQ) | Format | Monthly cost (MRP) |
|---|---|---|---|
| Semanat (generic semaglutide) | Natco Pharma (Hyderabad) | Vial | from ~₹1,290 |
| GLIPIQ (generic semaglutide) | Glenmark | Vial | ~₹1,300 (₹325/week) |
| Semasize (generic semaglutide) | Alkem | Prefilled pen | from ~₹1,800 |
| Semaglyn / Mashema | Zydus | Reusable cartridge pen | ~₹2,200 |
| Sematrinity / Noveltreat | Sun Pharma | Prefilled pen | ~₹3,000–8,000 by dose |
| Obeda injection | Dr. Reddy's (Hyderabad) | Pen | ~₹4,200 |
| Obeda oral tablets (launched 20 May 2026) | Dr. Reddy's (Hyderabad) | 3/7/14 mg tablets | ₹99/₹135/₹225 per tablet |
| Wegovy 0.25 mg (branded) | Novo Nordisk | Pen | ₹5,660 (post April-2026 cut) |
| Mounjaro (tirzepatide) 2.5→15 mg | Eli Lilly | KwikPen | ₹13,125 → ₹25,781 |
More than 40 DCGI-approved generic semaglutide brands were in circulation within weeks of patent expiry. Two honest caveats a pharma city will appreciate: first, generics replicate the molecule — semaglutide — so they're alternatives to Wegovy/Ozempic, not to Mounjaro, which is a different drug (tirzepatide) still under patent; if you're weighing that move, here's how a Mounjaro-to-generic-semaglutide switch works. Second, vials are cheaper than pens but require drawing up doses with a syringe; first-timers usually do better starting on a pen or under close supervision. To compare what each option costs at your dose over a full titration, calculate your monthly cost at your dose.
Where Hyderabad actually buys
- MedPlus. Headquartered in Hyderabad and blanketing the city, MedPlus is often the fastest stop for generic semaglutide brands; larger outlets stock branded pens too.
- Apollo Pharmacy. Densest around its Jubilee Hills hospital flagship and across Banjara Hills, Madhapur, Kukatpally, and Secunderabad; reliable for Mounjaro KwikPens and Wegovy against prescription.
- Hospital pharmacies. AIG (Gachibowli), Yashoda, KIMS, CARE, and Apollo hospital counters dispense cold-chain GLP-1s, including against outside prescriptions.
- Online cold-chain delivery. Apollo 24/7, Tata 1mg, PharmEasy and MrMed deliver across Hyderabad with ice packs; prescription upload mandatory.
- Avoid. Unverified resellers and "no prescription needed" channels. With a legal generic at ₹1,290 and a teleconsult available same-day, there is no economic excuse left for the grey market — which is where counterfeit pens live. Check seals and batch numbers, and confirm the product was refrigerated at handover.
Summer matters here: Hyderabad regularly crosses 40°C April–June. GLP-1 pens need 2–8°C storage, so insist on ice-pack packaging for delivery and refrigerate promptly. (Unopened pens kept briefly at room temperature per the label are fine — but don't leave one in a parked car in Madhapur in May. Our guide to GLP-1 storage in Indian heat has the exact out-of-fridge windows for every pen.)
Consultation costs: Hyderabad is the value market
Current Practo listings (June 2026) make Hyderabad the cheapest of India's five big GLP-1 metros for specialist access:
| Where | Area | Consult fee |
|---|---|---|
| Apollo Sugar Clinic | Jubilee Hills | ₹1,000 |
| CARE Hospitals OPD | Banjara Hills | ₹1,000 |
| Medicover | HiTec City / Financial District | ₹800–1,000 |
| Idea Clinics (endocrine chain) | KPHB & multiple | ₹900–1,000 |
| Aster Prime | Ameerpet | ₹500–800 |
| Standalone endocrine/diabetes clinics | Dilsukhnagar, Mehdipatnam, Karkhana, Pragathi Nagar | ₹300–900 |
Typical spend: ₹700–₹1,000 per visit — roughly half of Mumbai. Hyderabad also has something the other metros mostly don't: a deep bench of standalone endocrinology and diabetes super-speciality clinics (a legacy of the city's diabetes burden), so you aren't forced into corporate-hospital queues for titration follow-ups.
So why would a Hyderabadi go online at all? Three reasons that survive the cheap-consult argument: the HiTec City/Gachibowli workday doesn't accommodate monthly clinic queues even at ₹800; generic-brand selection genuinely benefits from a doctor who tracks all 40+ launches (most clinic visits end with whichever brand the attached pharmacy stocks); and side-effect management between visits — the thing that decides whether you quit in week 3 — doesn't exist in the walk-in model. If you've already had a dismissive clinic experience, here's how to find a doctor who treats obesity seriously.
How Kaivo works if you're in Hyderabad
Kaivo is an online, doctor-led GLP-1 program: video consultation with a registered physician, baseline blood panel with home sample collection anywhere in Hyderabad, and an e-prescription valid at any licensed pharmacy — MedPlus around the corner, Apollo 24/7 delivery, your choice. Kaivo never sells or marks up medication, which matters more than ever now that brand selection (innovator vs. eight generic makers) is a genuine clinical-plus-economic decision your doctor should make with you, not a pharmacy default. From there: structured 4-weekly titration reviews, message-based side-effect support, and a maintenance plan from day one. Trial benchmarks worth knowing: ~15% average weight loss at 68 weeks on semaglutide 2.4 mg (STEP-1) and up to ~20.9% at 72 weeks on tirzepatide (SURMOUNT-1).
Video consult, home labs anywhere in Hyderabad, and an e-prescription with zero medication markup — so the brand advice has no sales incentive behind it.
Reading from another city? See our guides for Bangalore, Mumbai, Delhi-NCR and Pune.
Sources
- CNBC-TV18 / Business Today — Indian semaglutide patent expiry (20 March 2026) and generic launches: Natco Semanat ~₹1,290/month, Sun Pharma from ₹750/week, Alkem from ₹1,800/month (March 2026); Dr. Reddy's Obeda oral tablets at ₹99/₹135/₹225 per tablet (20 May 2026).
- Reuters — Novo Nordisk India price reductions of up to 48% (Wegovy) and 36% (Ozempic), effective 1 April 2026; 0.25 mg starter dose ≈ ₹5,660/month.
- Eli Lilly India — Mounjaro (tirzepatide) KwikPen MRPs by dose (₹13,125 / ₹16,406 / ₹20,625 / ₹25,781 per month), corroborated by May 2026 price trackers; no price cut announced as of June 2026.
- Pharmarack (via Reuters / CNBC-TV18) — GLP-1 category MAT February 2026 ≈ ₹1,446 crore, +178% YoY; Mounjaro India's top-selling drug by value from October 2025.
- Practo — Hyderabad endocrinologist and clinic consultation fee listings, pulled June 2026; re-verified quarterly.
- Telemedicine Practice Guidelines, Board of Governors (MCI) / Ministry of Health & Family Welfare, 25 March 2020.
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1). NEJM 2021.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM 2022.
- Kaivo Research — Analysis of 3,001 posts and comments across India's largest GLP-1 community forum, May 2026 (city mention counts and brand-selection themes).